Searched for
BIOCON BIOSIMILARS
Biocon is becoming a credible force in biosimilars: Kirankiran.jpg11 Nov, 2010, 11.05 AM IST- Biocon to sell stake in biosimilar arm and Syngene: Sources15 Jan, 2024, 01.20 PM IST
- Biocon subsidiary completes acquisition of Viatris' Global Biosimilars business for USD 3 billion30 Nov, 2022, 09.47 AM IST
- There is compelling need to focus on Biosimilar from govt, patients' point of view: Kiran Mazumdar-Shaw27 Mar, 2019, 10.56 AM IST
- Mylan-Fujifilm tie-up to accelerate our entry in European market: Kiran Mazumdar Shaw12 Apr, 2018, 03.56 PM IST
- Watch: Kiran Mazumdar Shaw on USFDA approval to Biocon-Mylan's biosimilar drug04 Dec, 2017, 09.13 PM IST
- Faced a setback in March due to Covid, won't see a recovery soon: Kiran Mazumdar Shaw12 Jun, 2020, 02.12 PM IST
- In insulin bio-similars, our only competitors are original manufacturers: Kiran Mazumdar Shaw, Biocon14 Sep, 2020, 01.31 PM IST
- Biocon Q1 net profit declines 28% to Rs 149 crore24 Jul, 2020, 02.09 PM IST
Load More
